Sequencing.com introduces first agnostic platform for genetic data

Sequencing.com on Wednesday announced its global public launch with a platform that allows users to securely store, analyse and share their DNA information. According to the company, the "world's first agnostic platform for genetic data" is compatible with data produced by almost every genetic testing technology, including DNA microarrays, whole genome sequencing and exome sequencing, such as those marketed by Illumina, Helix and 23andMe. 

CEO Brandon Colby estimated that "within the next eight years, we expect that between 100 million and two billion human genomes will be sequenced." He added that the platform "provides the ability for everyone to keep their genetic data safe, while also being able to use it on a daily basis to personalise and improve their lives."

The platform includes an "app market" that allows individuals, researchers, bioinformaticians and healthcare professionals to access the data, with the company offering free and unlimited data storage. Sequencing.com said that over 25 apps are available for immediate use, while several more are being developed. Specifically, the Wellness & Longevity app generates lifestyle recommendations for optimal health, the Healthcare Pro app gives physicians access to actionable genetic reports and the EvE app enables researchers and bioinformaticians to perform free analyses of genetic data, the company added.

Did you like this article?